Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ).
WuXi AppTec has made a further grant of 126,240 existing H shares under its 2024 H Share Award and Trust Scheme to 24 independent senior, mid-level and basic-level managers, representing about 0.0247% of its issued H shares and 0.0042% of its total share capital. The shares, which were acquired on-market by a trustee and do not involve new issuance, avoid dilution for existing shareholders, and the board, including independent non-executive directors, considers the grant to be on normal commercial terms and in the interests of the company and its shareholders, underscoring continued use of equity incentives to retain and motivate key management talent.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$111.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a China-incorporated joint stock company listed in Hong Kong that operates in the pharmaceutical and life sciences services industry, providing research, development and manufacturing services for global healthcare and biopharmaceutical clients. The group leverages its H-share listing to incentivize management and key employees through equity-based award and trust schemes aimed at aligning staff interests with long-term shareholder value.
Average Trading Volume: 5,499,885
Technical Sentiment Signal: Buy
Current Market Cap: HK$307.4B
See more data about 2359 stock on TipRanks’ Stock Analysis page.